 | • レポートコード：MRC2-11QY04558 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は強皮症治療ソリューションのグローバル市場について調査・分析したレポートです。種類別（免疫療法、抗線維化薬、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別強皮症治療ソリューションの競争状況、市場シェア ・世界の強皮症治療ソリューション市場：種類別市場規模 2015年-2020年（免疫療法、抗線維化薬、その他） ・世界の強皮症治療ソリューション市場：種類別市場規模予測 2021年-2026年（免疫療法、抗線維化薬、その他） ・世界の強皮症治療ソリューション市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の強皮症治療ソリューション市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の強皮症治療ソリューション市場分析：米国、カナダ ・ヨーロッパの強皮症治療ソリューション市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの強皮症治療ソリューション市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の強皮症治療ソリューション市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの強皮症治療ソリューション市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Merck、AbbVie、Bristol-Myers Squibb、Sanofi、Roche、GlaxoSmithKline、Pfizer、Boehringer Ingelheim、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Scleroderma Therapy Solutions Market
The global Scleroderma Therapy Solutions market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Scleroderma Therapy Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Scleroderma Therapy Solutions market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Scleroderma Therapy Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Scleroderma Therapy Solutions market.
Global Scleroderma Therapy Solutions Scope and Market Size
Scleroderma Therapy Solutions market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Scleroderma Therapy Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Immunotherapy
Anti-Fibrotic Drugs
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Based on regional and country-level analysis, the Scleroderma Therapy Solutions market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Scleroderma Therapy Solutions market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Bayer
Merck
AbbVie
Bristol-Myers Squibb
Sanofi
Roche
GlaxoSmithKline
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Scleroderma Therapy Solutions Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Immunotherapy
1.2.3 Anti-Fibrotic Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Scleroderma Therapy Solutions Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Scleroderma Therapy Solutions Market Perspective (2015-2026)
2.2 Global Scleroderma Therapy Solutions Growth Trends by Regions
2.2.1 Scleroderma Therapy Solutions Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Scleroderma Therapy Solutions Historic Market Share by Regions (2015-2020)
2.2.3 Scleroderma Therapy Solutions Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Scleroderma Therapy Solutions Players by Market Size
3.1.1 Global Top Scleroderma Therapy Solutions Players by Revenue (2015-2020)
3.1.2 Global Scleroderma Therapy Solutions Revenue Market Share by Players (2015-2020)
3.2 Global Scleroderma Therapy Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Scleroderma Therapy Solutions Revenue
3.4 Global Scleroderma Therapy Solutions Market Concentration Ratio
3.4.1 Global Scleroderma Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Scleroderma Therapy Solutions Revenue in 2019
3.5 Key Players Scleroderma Therapy Solutions Area Served
3.6 Key Players Scleroderma Therapy Solutions Product Solution and Service
3.7 Date of Enter into Scleroderma Therapy Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Scleroderma Therapy Solutions Breakdown Data by Type (2015-2026)
4.1 Global Scleroderma Therapy Solutions Historic Market Size by Type (2015-2020)
4.2 Global Scleroderma Therapy Solutions Forecasted Market Size by Type (2021-2026)
5 Scleroderma Therapy Solutions Breakdown Data by Application (2015-2026)
5.1 Global Scleroderma Therapy Solutions Historic Market Size by Application (2015-2020)
5.2 Global Scleroderma Therapy Solutions Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Scleroderma Therapy Solutions Market Size (2015-2026)
6.2 North America Scleroderma Therapy Solutions Market Size by Type (2015-2020)
6.3 North America Scleroderma Therapy Solutions Market Size by Application (2015-2020)
6.4 North America Scleroderma Therapy Solutions Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Scleroderma Therapy Solutions Market Size (2015-2026)
7.2 Europe Scleroderma Therapy Solutions Market Size by Type (2015-2020)
7.3 Europe Scleroderma Therapy Solutions Market Size by Application (2015-2020)
7.4 Europe Scleroderma Therapy Solutions Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Scleroderma Therapy Solutions Market Size (2015-2026)
8.2 China Scleroderma Therapy Solutions Market Size by Type (2015-2020)
8.3 China Scleroderma Therapy Solutions Market Size by Application (2015-2020)
8.4 China Scleroderma Therapy Solutions Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Scleroderma Therapy Solutions Market Size (2015-2026)
9.2 Japan Scleroderma Therapy Solutions Market Size by Type (2015-2020)
9.3 Japan Scleroderma Therapy Solutions Market Size by Application (2015-2020)
9.4 Japan Scleroderma Therapy Solutions Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Scleroderma Therapy Solutions Market Size (2015-2026)
10.2 Southeast Asia Scleroderma Therapy Solutions Market Size by Type (2015-2020)
10.3 Southeast Asia Scleroderma Therapy Solutions Market Size by Application (2015-2020)
10.4 Southeast Asia Scleroderma Therapy Solutions Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Scleroderma Therapy Solutions Introduction
11.1.4 Bayer Revenue in Scleroderma Therapy Solutions Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Scleroderma Therapy Solutions Introduction
11.2.4 Merck Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.2.5 Merck Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Scleroderma Therapy Solutions Introduction
11.3.4 AbbVie Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Scleroderma Therapy Solutions Introduction
11.4.4 Bristol-Myers Squibb Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Scleroderma Therapy Solutions Introduction
11.5.4 Sanofi Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Scleroderma Therapy Solutions Introduction
11.6.4 Roche Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.6.5 Roche Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Scleroderma Therapy Solutions Introduction
11.7.4 GlaxoSmithKline Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Scleroderma Therapy Solutions Introduction
11.8.4 Pfizer Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.8.5 Pfizer Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Scleroderma Therapy Solutions Introduction
11.9.4 Boehringer Ingelheim Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Scleroderma Therapy Solutions Introduction
11.10.4 Novartis Revenue in Scleroderma Therapy Solutions Business (2015-2020)
11.10.5 Novartis Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Scleroderma Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Anti-Fibrotic Drugs
Table 5. Key Players of Others
Table 6. Global Scleroderma Therapy Solutions Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Scleroderma Therapy Solutions Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Scleroderma Therapy Solutions Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Scleroderma Therapy Solutions Market Share by Regions (2015-2020)
Table 10. Global Scleroderma Therapy Solutions Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Scleroderma Therapy Solutions Market Share by Regions (2021-2026)
Table 12. Scleroderma Therapy Solutions Market Market Trends
Table 13. Scleroderma Therapy Solutions Market Drivers
Table 14. Scleroderma Therapy Solutions Market Challenges
Table 15. Scleroderma Therapy Solutions Market Restraints
Table 16. Global Scleroderma Therapy Solutions Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Scleroderma Therapy Solutions Market Share by Players (2015-2020)
Table 18. Global Top Scleroderma Therapy Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Scleroderma Therapy Solutions as of 2019)
Table 19. Global Scleroderma Therapy Solutions by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Scleroderma Therapy Solutions Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Scleroderma Therapy Solutions Market Size Share by Type (2015-2020)
Table 25. Global Scleroderma Therapy Solutions Revenue Market Share by Type (2021-2026)
Table 26. Global Scleroderma Therapy Solutions Market Size Share by Application (2015-2020)
Table 27. Global Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Scleroderma Therapy Solutions Market Size Share by Application (2021-2026)
Table 29. North America Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Scleroderma Therapy Solutions Market Share by Type (2015-2020)
Table 31. North America Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Scleroderma Therapy Solutions Market Share by Application (2015-2020)
Table 33. North America Scleroderma Therapy Solutions Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Scleroderma Therapy Solutions Market Share by Country (2015-2020)
Table 35. Europe Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Scleroderma Therapy Solutions Market Share by Type (2015-2020)
Table 37. Europe Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Scleroderma Therapy Solutions Market Share by Application (2015-2020)
Table 39. Europe Scleroderma Therapy Solutions Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Scleroderma Therapy Solutions Market Share by Country (2015-2020)
Table 41. China Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 42. China Scleroderma Therapy Solutions Market Share by Type (2015-2020)
Table 43. China Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 44. China Scleroderma Therapy Solutions Market Share by Application (2015-2020)
Table 45. China Scleroderma Therapy Solutions Market Size by Region (US$ Million) (2015-2020)
Table 46. China Scleroderma Therapy Solutions Market Share by Region (2015-2020)
Table 47. Japan Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Scleroderma Therapy Solutions Market Share by Type (2015-2020)
Table 49. Japan Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Scleroderma Therapy Solutions Market Share by Application (2015-2020)
Table 51. Japan Scleroderma Therapy Solutions Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Scleroderma Therapy Solutions Market Share by Country (2015-2020)
Table 53. Southeast Asia Scleroderma Therapy Solutions Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Scleroderma Therapy Solutions Market Share by Type (2015-2020)
Table 55. Southeast Asia Scleroderma Therapy Solutions Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Scleroderma Therapy Solutions Market Share by Application (2015-2020)
Table 57. Southeast Asia Scleroderma Therapy Solutions Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Scleroderma Therapy Solutions Market Share by Country (2015-2020)
Table 59. Bayer Company Details
Table 60. Bayer Business Overview
Table 61. Bayer Product
Table 62. Bayer Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 63. Bayer Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Product
Table 67. Merck Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 68. Merck Recent Development
Table 69. AbbVie Company Details
Table 70. AbbVie Business Overview
Table 71. AbbVie Product
Table 72. AbbVie Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 73. AbbVie Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Product
Table 77. Bristol-Myers Squibb Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Product
Table 82. Sanofi Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 88. Roche Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 93. GlaxoSmithKline Recent Development
Table 94. Pfizer Business Overview
Table 95. Pfizer Product
Table 96. Pfizer Company Details
Table 97. Pfizer Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Boehringer Ingelheim Company Details
Table 100. Boehringer Ingelheim Business Overview
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Scleroderma Therapy Solutions Business (2015-2020) (US$ Million)
Table 108. Novartis Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Scleroderma Therapy Solutions Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapy Features
Figure 3. Anti-Fibrotic Drugs Features
Figure 4. Others Features
Figure 5. Global Scleroderma Therapy Solutions Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Scleroderma Therapy Solutions Report Years Considered
Figure 10. Global Scleroderma Therapy Solutions Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Scleroderma Therapy Solutions Market Share by Regions: 2020 VS 2026
Figure 12. Global Scleroderma Therapy Solutions Market Share by Regions (2021-2026)
Figure 13. Global Scleroderma Therapy Solutions Market Share by Players in 2019
Figure 14. Global Top Scleroderma Therapy Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Scleroderma Therapy Solutions as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Scleroderma Therapy Solutions Revenue in 2019
Figure 16. North America Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Scleroderma Therapy Solutions Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Bayer Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 44. Merck Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 45. AbbVie Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 47. Sanofi Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 48. Roche Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 50. Pfizer Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 52. Novartis Revenue Growth Rate in Scleroderma Therapy Solutions Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
強皮症診断・治療の世界市場（～2026年） Market Analysis and Insights: Global Scleroderma Diagnostics and Therapeutics Market The global Scleroderma Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Scleroderma Diagnostics and Thera…- スピーチセラピーサービスの世界市場（～2026年） Speech therapy services involves the treatment of communication and speech related disorders. North America is estimated to lead the global speech therapy services market due to rise in incidence of congenital disorders, increase in elderly population etc. Market Analysis and Insights: Global Speech…
- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 陽子線治療の世界市場（～2026年） Ionizing radiations are used to treat cancer and the procedure is known as radiation therapy. When the ionizing radiations are made up of charged particles such as protons, carbon, and other ions, then radiation therapy is called as hadron therapy. Market Analysis and Insights: Global Proton Therapy…
- 外来在宅療法の世界市場（～2026年） Outpatient home therapy provides treatment at the patient’s home. Outpatient home therapy provides extra comfort to the patients and is regulated by the Medicare and Medicaid programs. Home therapy is useful when patients are not able to travel to the healthcare units due to lack of transportation o…